MCID/low disease activity state workshop: Low disease activity state in rheumatoid arthritis

George Wells*, Maarten Boers, Beverley Shea, Jennifer Anderson, David Felson, Kent Johnson, John Kirwan, Marissa Lassere, Vivian Robinson, Lee Simon, Vibeke Strand, Piet Van Riel, Peter Tugwell

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

29 Citations (Scopus)

Abstract

The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda that led to the conclusion that a state of low disease activity for rheumatoid arthritis (RA) would need to be defined. To develop such a definition the various concepts and terminologies, the process for developing an operational definition, and the availability and design of longitudinal datasets for validation needed to be considered. This article describes the process of the MCID/Low Disease Activity State Workshop at OMERACT 6 to develop such a definition.

Original languageEnglish
Pages (from-to)1110-1111
Number of pages2
JournalJournal of Rheumatology
Volume30
Issue number5
Publication statusPublished - 1 May 2003

Keywords

  • Disease activity
  • Outcome assessment
  • Rheumatoid arthritis

Fingerprint

Dive into the research topics of 'MCID/low disease activity state workshop: Low disease activity state in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this